GlobalRPh RX List - KIRSTY
- Product / population
- Selected single-dose renal pharmacokinetic study for KIRSTY insulin aspart.
- Renal measure
- Renal impairment groups in a small study; no creatinine-based dose algorithm.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
The selected study did not show an apparent effect of renal impairment on single-dose insulin-aspart pharmacokinetics. This is not a no-adjustment rule for clinical insulin needs and does not replace individualized glucose monitoring, meal assessment or hypoglycemia precautions. No dialysis-specific regimen is established here.